A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA
Clinical trial NCT03316131 · COMPLETED
Trial details
- NCT number
- NCT03316131
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-25
- Primary completion
- 2018-07-19
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.